Notably Indexed | Fully Open Access | Oncology Journals

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Oncology

Open Access at Taylor & Francis

Explore Portfolio

Looking to publish your next article?

Find the perfect home for your research. Each journal in this portfolio is PubMed indexed, peer-reviewed and fully open access; aiming to serve the academic research community, scientific community and practitioner community.

The below journals have various specialties in:

  • Tumor immunology, immunological biomarkers and anticancer therapies with immunotherapies
  • Thermal energy-based disease treatment, either clinical studies, biological studies or physics and engineering
  • Antibody research and development
  • Blood and lymphatic cancer research
  • Molecular diagnosis of and targeted molecular or precision therapy for all types of cancer
  • Hepatobiliary tumors
  • Application of oncolytic viruses for the treatment of cancer

Find out if your institution or country has an open access agreement to publish with us.

Publishing open access increases the visibility and readership of your research, helping you make an impact beyond your field.
Find Out More

OncoImmunology

2019 Impact Factor 5.869
Five-Year Impact Factor 6.255

Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.

Visit Journal Submit

International Journal of Hyperthermia

2019 Impact Factor 3.574
Five-Year Impact Factor 3.594

The International Journal of Hyperthermia publishes peer reviewed research and clinical studies on thermal energy-based disease treatments.

Visit Journal Submit


 

Hematology

2019 Impact Factor 1.650
Five-Year Impact Factor 1.406

Publishing original and review articles in the field of general hematology, and interdisciplinary areas of research related to general hematology, including oncology.

Visit Journal Submit

mAbs

2019 Impact Factor 4.634
Five-Year Impact Factor 4.981

mAbs publishes antibody research on topics including targets relevant to cancer and immune-mediated disorders, and antibody therapeutics.

Visit Journal Submit


 

Blood and Lymphatic Cancer: Targets and Therapy

A Dove Medical Press journal

This journal focuses on blood and lymphatic cancer research, the identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.

Visit Journal

Cancer Management and Research

A Dove Medical Press journal
2019 Impact Factor 2.886 (5 year impact 3.000)

This journal focuses on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.

Visit Journal

OncoTargets and Therapy

A Dove Medical Press journal
2019 Impact Factor 3.337 (5 year impact 3.044)

This journal focuses on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

Visit Journal


 

Journal of Hepatocellular Carcinoma

A Dove Medical Press journal
2019 Impact Factor 4.655

The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.

Visit Journal

Oncolytic Virotherapy

A Dove Medical Press journal

The journal publishes original research, study protocols, reviews, editorials and commentaries on all aspects of oncolytic virology, namely the application of oncolytic viruses for the treatment of cancer.

Visit Journal

Questions about the publishing process?

Visit our dedicated and ever-expanding site for authors, Author Services, to find out more about how to get published and your publishing options.
Find Out More

SHARE THIS PAGE

F1000Research is an Open Research publishing platform for scientists, scholars and clinicians, supporting data deposition and sharing. Publish all your findings including null results, data notes and more.
Go To F1000Research
Dove Medical Press is part of the Taylor & Francis Group, specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
Go To Dove Press

Latest tweets from @tandfmedicine